Cases & Deals

  • Home
  • Practices
  • Huadong Medicine invests in R2 Dermatology and enters into distribution agreement

Share

Huadong Medicine invests in R2 Dermatology and enters into distribution agreement

June 2019

Client(s) Huadong Medicine Co. Ltd.

Jones Day advised Huadong Medicine Co. Ltd., a Chinese manufacturer and distributor of pharmaceutical and other medical products, in connection with its subscription of Series B Preferred Shares of R2 Dermatology, Inc., and the negotiation of a distribution agreement authorizing Huadong Medicine as an exclusive distributor in Asia for R2's skin whitening products.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.